Nicolas Gendron
LightNews LightNews
banner
gendronn.bsky.social
Nicolas Gendron
@gendronn.bsky.social
1K followers 190 following 120 posts
🔴 Hematologist 🇺🇸 Research fellow @BostonChildrens.bsky.social @HarvardMed.bsky.social
#Thrombosis #Thrombophilia #CVcoag

Ex: 🇫🇷 @hopitalpompidou.bsky.social
@upcite.bsky.social @parcc-inserm.bsky.social‬ Team #Endotheliopathy and #Hemostasis disorders
Posts Replies Media Videos
gendronn.bsky.social
Program of the next 3 days!
#PCMM #Retreat #CapeCod
@harvardmed.bsky.social @bostonchildrens.bsky.social
September 16, 2025 at 3:21 AM
gendronn.bsky.social
New study in #Blood VTH:
We show that the AcuStar HIT-IgG (Werfen) CLIA is a reliable & fast ⏱️ diagnostic tool for #HIT with strong agreement vs anti-PFA/H ELISA (Hyphen) & SRA
@davidmsmadja.bsky.social @hopitalpompidou.bsky.social
@bloodjournals.hematology.org
ashpublications.org/bloodvth/art...
September 12, 2025 at 1:18 AM
gendronn.bsky.social
Great session on #thrombophilia at #ISTH2025!
@bhwords.bsky.social presented the upcoming @isth.org guidance on thrombophilia testing, very clear and well-structured. I fully agree with the proposals. 🙂 Excellent discussions during the session.
June 24, 2025 at 2:31 PM
gendronn.bsky.social
Very interesting oral communication about comparison of an Al-Based App 🤳🩸(MEASUREmenses ™) and #PBAC for Evaluating Menstrual Bleeding.
➡️ Need to be validated on differents type of pads.
#ISTH2025 #AUB #HMB
@isth.org
June 23, 2025 at 3:27 PM
gendronn.bsky.social
📉 Proud to have presented our 5-year single-center retrospective study on 💉danaparoid use in patients with suspected HIT
➡️ anti-Xa levels were not linked to bleeding, but lower levels were associated with higher thrombotic risk.
#ISTH2025

@hopitalpompidou.bsky.social
@davidmsmadja.bsky.social
June 22, 2025 at 9:22 PM
gendronn.bsky.social
📊 Thrilled to share our retrospective study comparing the anti-PF4/H IgG ELISA Zymutest (Hyphen) with the AcuStar chemiluminescent IgG anti-PF4/H assay for the diagnosis of heparin-induced thrombocytopenia. #ISTH2025 #HIT
The paper is now in press in @bloodvth.bsky.social
@davidmsmadja.bsky.social
June 22, 2025 at 9:10 PM
gendronn.bsky.social
Amazing results of the COBRRA study
➡️ First RCT head-to-head comparison between Apixaban and rivaroxaban.
Apixaban was safer than rivaroxaban for the treatment of acute DVT 🩸
👏🏻👏🏻 Congratulations Lana and collaborators.
@isth.org #ISTH2025 #DOAC
June 22, 2025 at 1:49 PM
gendronn.bsky.social
🤗Proud to share at #ISTH2025 🇺🇸our latest SSC guidance from the Control of Anticoagulation on oral FXa inhibitors and heparin anti-Xa activity
@isth.org @hopitalpompidou.bsky.social @upcite.bsky.social
June 22, 2025 at 2:56 AM
gendronn.bsky.social
That’s true 😅🩸
April 8, 2025 at 3:28 AM
gendronn.bsky.social
Je vois passer ça concernant ma ville natale #Carcassonne.
🤦🏻‍♂️ Pour voir un film en VO faut toujours « se lever tôt » en 2025 ! Rien ne change alors que les salles sont modernes.
🫣Ne pas s’étonner du niveau en anglais des Français et des disparités avec les grandes villes Françaises comme Paris
February 1, 2025 at 5:53 PM
gendronn.bsky.social
😵Just discovered what may be the first case of a VITT-like condition following an infection in a young patient was French 🇫🇷, reported in 2010 and published in a French journal. You can translate the article for more information. #antiPF4 #VITT #HIT

🔗 pubmed.ncbi.nlm.nih.gov/21159583/
December 16, 2024 at 10:14 PM
gendronn.bsky.social
🎁🎄How to avoid gifts from your patients after the Christmas holidays? 🎅

🤩 Incredible and true French 🇫🇷study 👏

Almost Christmas @bmj.com

www.sciencedirect.com/science/arti...
December 9, 2024 at 11:04 PM
gendronn.bsky.social
Heureux de partager la publication de notre synthèse dans 📚EMC Angiologie sur l'𝐢𝐧𝐭𝐞𝐫𝐩𝐫𝐞́𝐭𝐚𝐭𝐢𝐨𝐧 𝐚𝐜𝐭𝐮𝐞𝐥𝐥𝐞 𝐝𝐞𝐬 𝐚𝐧𝐨𝐦𝐚𝐥𝐢𝐞𝐬 𝐝𝐮 𝐛𝐢𝐥𝐚𝐧 𝐝'𝐡𝐞́𝐦𝐨𝐬𝐭𝐚𝐬𝐞 𝐝𝐞 𝐫𝐨𝐮𝐭𝐢𝐧𝐞 🧪🩸 en 2024, avec un accent particulier sur l'impact des anticoagulants oraux directs 💊 sur les tests d'hémostase

www.em-consulte.com/article/1697...
November 17, 2024 at 8:05 PM
gendronn.bsky.social
📊 Où en sommes nous du développement des nouveaux anticoagulants anti-FXI et anti-FXIa en 2024❓
💉La percée des anticorps monoclonaux.
💊 Le doute sur l'efficacité d'un anti-FXIa oral

🌐 Notre review 🇫🇷 dans les Annales de Biologie Clinique

www.jle.com/fr/revues/ab...
November 17, 2024 at 8:18 PM
gendronn.bsky.social
🫡OK, message reçu ! 😅🫣
November 17, 2024 at 8:18 PM
gendronn.bsky.social
🗞️En ligne dans #ThrombosisResearch notre edito sur la place des AOD 💊et leur suivi biologique chez les patients beneficiant d’une chirurgie bariatrique.

➡️DOACs: A perfect fit for patients with bariatric surgery?

www.sciencedirect.com/science/arti...
November 17, 2024 at 8:18 PM
gendronn.bsky.social
☹️Où sont les poubelles marron ? Par Gaspard Koening ♻️🗑️🥕🥒 #vers @lesechos #Humus 🪱
November 17, 2024 at 8:18 PM
gendronn.bsky.social
🎉 Très heureux de vous partager notre travail collaboratif avec David Lebeaux sur la fréquence des complications hémorragiques chez les patients traités par céfazoline.
#HEGP #Infection 💉🩸🦠🏥

▶️ link.springer.com/article/10.1...
November 17, 2024 at 8:18 PM
gendronn.bsky.social
Tellement vrai …
November 17, 2024 at 8:18 PM
gendronn.bsky.social
On sait s’amuser le week-end 😅😅😅 #Thrombophilie #Quiz #Thrombose
November 17, 2024 at 8:18 PM
gendronn.bsky.social
😮Personnellement, je vais rester à la biere…. #BlueBalls
November 17, 2024 at 8:18 PM
gendronn.bsky.social
Le Cassoulet 🤩 au programme d’On Va Déguster 😋😋😛 @franceinter.bsky.social
November 17, 2024 at 8:18 PM
gendronn.bsky.social
Meanwhile in Paris 😅.
📍rue Oberkampf
November 17, 2024 at 8:18 PM
gendronn.bsky.social
🤓👨🏻‍🏫
November 17, 2024 at 8:18 PM
gendronn.bsky.social
💡Très heureux de pouvoir partager notre expérience de l’argatroban chez pour irriguer les lambeaux de 2 patients avec Thrombopénie induite à l’héparine et allergique à l’heparine #TIH #HEGP #Argatroban
#PlasticSurgery
www.jprasurg.com/article/S174...
November 17, 2024 at 8:18 PM